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Addressing complex public health prob-
lems, such as smoking, obesity and mental 
health, requires complex, often multilevel, 
interventions. Given the costs associated 
with delivering such interventions and the 
possibility of unanticipated harm, they 
need to be evaluated using the most robust 
methods available. It is important, where 
possible, that public health interventions 
and their proposed evaluation designs are 
optimised prior to being subject to an 
expensive evaluation of their effective-
ness, through rigorous assessment of their 
feasibility.1 Consequently, a growing 
number of exploratory studies (ie, studies 
intended to generate the evidence needed 
to decide whether and how to proceed 
with a full-scale evaluation, also (inconsis-
tently) referred to as ‘pilot’ or ‘feasibility’ 
studies) are being conducted. These gener-
ally have one, or both, of the following 
objectives: to optimise or assess the (1) 
feasibility of the intervention or (2) design 
of the full-scale effectiveness evaluation. 
However, conflicting guidance exists 
regarding what exploratory studies should 
be called, what they should achieve, what 
they should entail, whether and how they 
should determine progression to future 
studies and how they should be reported.2 3 
This presents a challenge for researchers 
in designing and conducting exploratory 
studies, and for peer reviewers and funders 
in judging the merits of research proposals 
and outputs. This paper briefly discusses 
these issues, before describing current 
work funded by the Medical Research 
Council (MRC)/National Institute of 
Health Research (NIHR) Methodology 
Research Programme to develop GUid-
ance for Exploratory STudies of complex 
public health interventions (henceforth 
referred to as the GUEST study).
There is increasing recognition that 
pressure to identify effective interven-
tions has led to premature commissioning 
of large-scale evaluation trials of poorly 
developed interventions, wasting finite 
resource.1 4 In the development of phar-
maceuticals, over 80% fail to reach ‘Phase 
III’ effectiveness trials, even after consid-
erable investment.5 Yet, with public health 
interventions there has been a tendency to 
rush to full evaluations, which commonly 
fail due to issues which could have been 
identified at a feasibility stage, such as the 
acceptability or feasibility of the interven-
tion or difficulties recruiting or retaining 
participants. The importance of estab-
lishing the feasibility of the intervention 
and evaluation plans prior to embarking 
on an expensive, fully powered evaluation 
study was indicated in the MRC Guid-
ance on the Development and Evaluation 
of Complex Interventions.6 7 In more 
recent years, major funders, such as the 
NIHR Public Health Research Funding 
Programme, have begun to fund a large 
number of pilot and feasibility studies, 
while the MRC has established the Public 
Health Intervention Development funding 
panel, increasing the volume of pre-evalu-
ation research in public health. This has 
facilitated a shift towards an expectation 
that exploratory studies will address feasi-
bility issues before funding a full-scale 
evaluation will be considered, including 
assessing the extent to which these issues 
are context dependent and the identifica-
tion of an intervention’s mechanisms of 
change.8 9
Nevertheless, the extent to which 
substantial investment in exploratory 
studies has to date improved the effective-
ness and cost-effectiveness of evidence 
production processes remains to be firmly 
established. Recently funded exploratory 
studies demonstrate that they can be 
costly (often between £300 and £500 k).10 
If conducted poorly, this investment may 
lead to significant extra expenditure 
and several years’ delay in generating 
evidence, without necessarily increasing 
the likelihood that future evaluation will 
produce useful evidence. Examples are 
emerging of interventions which were 
assessed through a substantial feasibility 
and piloting phase, but still reported 
substantial problems with intervention 
implementation or study recruitment and 
retention at full evaluation stage. On the 
other hand, the imperative to test every 
potential uncertainty prior to full evalua-
tion may have in some cases gone too far, 
with exploratory studies testing issues for 
which prior literature indicates minimal 
uncertainty. For example, the feasibility 
of randomisation in school-based inter-
ventions has been widely demonstrated. 
Nevertheless, many exploratory studies 
of school-based interventions continue 
to randomise, serving no purpose other 
than re-establishing (at great cost) that 
which we already know to be feasible. 
In such cases, studies could be more effi-
cient through testing the intervention in 
all included schools to understand imple-
mentation in a wider range of contexts, 
or simply by not recruiting an unneces-
sary control group, reducing study cost. 
Finally, the suitability of exploratory 
studies to achieve certain aims may 
depend on their design. For example, 
use of exploratory studies to understand 
mechanisms may take the form of in-depth 
qualitative work or assessment of impacts 
on immediate proximal outcomes on the 
hypothesised causal pathway (provided 
there is power to do so).
The MRC guidance of 2000 used the 
term ‘exploratory trial’ for the work 
immediately prior to a ‘definitive trial’. In 
addition to evaluating key design compo-
nents like recruitment and retention, it 
argued that an exploratory study should 
address issues concerning the optimis-
ation, acceptability and delivery of the 
intervention. Not all research funding 
bodies, however, have as inclusive a 
concept of the potential goals of explor-
atory trials within their published defini-
tions. For instance, the NIHR Evaluation 
Trials and Studies Coordinating Centre’s 
definitions of feasibility and pilot studies 
do not include any examination of inter-
vention design, delivery or acceptability, 
nor do they suggest that modifications to 
the intervention prior to full scale evalu-
ation will arise from these phases (http://
www. netscc. ac. uk/ glossary/). However, 
the NIHR portfolio of funded studies 
includes various terms such as ‘feasibility 
trial’, ‘pilot trial’ and ‘exploratory trial’ to 
describe funded studies with similar aims. 
In practice, such studies are rarely limited 
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to exploration of methodological uncer-
tainties, to the exclusion of uncertainties 
relating to intervention implementation.11
Guidance for exploratory studies has 
often been framed as relevant only where 
the main evaluation is to be a randomised 
trial.7 12 Previous MRC guidance in 2000 
focused solely on randomised controlled 
trials, although updated MRC guidance 
in 2008 moved away from this, reflecting 
the recognition that for some public 
health interventions, randomised trials are 
not feasible or appropriate and rigorous 
non-randomised alternative designs, 
including natural experiment evaluations, 
are required. This highlights a possible gap 
in guidance for exploratory studies that 
might progress to non-randomised eval-
uation designs. In natural experimental 
evaluations, for example, the researcher 
will usually have no control over the inter-
vention, while the time-sensitive nature of 
such work may sometimes force evalua-
tors to go straight to evaluation without 
assessment of feasibility. However, where 
possible, exploratory studies in prepara-
tion for natural experimental evaluations 
are, nevertheless, important for addressing 
uncertainties about intervention compo-
nents and their underlying logic, 
informing identification and selection of 
appropriate outcome measures and iden-
tifying implementation uncertainties to be 
addressed through process evaluation at 
the full evaluation stage. Addressing these 
gaps in the literature and providing effec-
tive guidance on exploratory studies will 
help ensure that the most promising inter-
ventions are evaluated in a timely fashion 
using the most feasible, rigorous designs, 
minimising expenditure of scarce resource 
on poor-quality evaluations of underde-
veloped interventions.
OVERVIEW OF GUEST STUDY
In developing new guidance, our study 
will examine current practice and expert 
consensus in relation to uncertainties that 
should be addressed prior to full evalua-
tions of complex public health interven-
tions, methodological considerations in 
addressing these uncertainties and deci-
sion-making regarding whether and how 
to progress to evaluation of effectiveness 
following the conduct of an exploratory 
study. The guidance is being developed 
through activities which include: (1) a 
systematic review of guidance on explor-
atory studies; (2) an audit of current 
practice; (3) a web-based DELPHI exer-
cise to identify expert consensus on the 
purpose, design and conduct of explor-
atory studies involving consultation with 
stakeholders and (4) a horizon scan of 
novel approaches to intervention optimi-
sation and exploratory study designs from 
other contexts within and outside health 
research. Guidance will not be limited to 
exploratory studies of a specific design 
and will assist researchers in public health 
to more efficiently and effectively develop 
and conduct exploratory studies, while 
providing peer reviewers and research 
funders with objective criteria against 
which to assess the quality of bids and 
publications. This will likely have substan-
tial impacts on the health and well-being 
of the population and on the effectiveness 
and efficiency of preventive services and 
policies, by increasing rigorous and reli-
able evidence of what does and does not 
work.
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